We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16.9B
AUM Growth
+$588M
Cap. Flow
+$89.1M
Cap. Flow %
0.53%
Top 10 Hldgs %
18.71%
Holding
742
New
20
Increased
188
Reduced
506
Closed
5

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$52.6M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$35.1M
3
V icon
Visa
V
+$32.9M
4
LVS icon
Las Vegas Sands
LVS
+$31.4M
5
AMAT icon
Applied Materials
AMAT
+$26M

Top Sells

Rank Stock Value
1
GLIN icon
VanEck India Growth Leaders ETF
GLIN
+$57.5M
2
MO icon
Altria Group
MO
+$42.9M
3
TWX
Time Warner Inc
TWX
+$37.4M
4
MMM icon
3M
MMM
+$33.3M
5
MON
Monsanto Co
MON
+$26.8M

Sector Composition

Rank Sector Weight
1 Technology 17.74%
2 Financials 16.91%
3 Healthcare 13.21%
4 Consumer Discretionary 10.2%
5 Communication Services 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RY icon
76
Royal Bank of Canada
RY
$287B
$54.9M 0.32%
732,119
-10,820
-1% -$828K
ACN icon
77
Accenture
ACN
$106B
$54.8M 0.32%
335,285
+8,431
+3% +$1.31M
GILD icon
78
Gilead Sciences
GILD
$165B
$54.3M 0.32%
766,515
-10,705
-1% -$756K
BMY icon
79
Bristol-Myers Squibb
BMY
$129B
$54.1M 0.32%
977,131
-13,152
-1% -$710K
IWV icon
80
iShares Russell 3000 ETF
IWV
$19.2B
$53.8M 0.32%
331,709
-18,516
-5% -$2.98M
BLK icon
81
Blackrock
BLK
$167B
$53.7M 0.32%
107,581
+13,939
+15% +$7.37M
TJX icon
82
TJX Companies
TJX
$179B
$53.2M 0.31%
1,118,216
-19,650
-2% -$863K
SHW icon
83
Sherwin-Williams
SHW
$83.5B
$52.8M 0.31%
388,845
-109,038
-22% -$14.1M
DLR icon
84
Digital Realty Trust
DLR
$69.6B
$51.7M 0.31%
463,488
-10,841
-2% -$1.15M
SPGI icon
85
S&P Global
SPGI
$124B
$51.7M 0.31%
253,549
-54,419
-18% -$10.8M
GGP
86
DELISTED
GGP Inc.
GGP
$51.1M 0.3%
2,502,887
-20,886
-0.8% -$424K
MU icon
87
Micron Technology
MU
$835B
$51M 0.3%
972,877
+18,997
+2% +$1.03M
PX
88
DELISTED
Praxair Inc
PX
$50.1M 0.3%
316,733
-19,050
-6% -$2.94M
AGN
89
DELISTED
Allergan plc
AGN
$48M 0.28%
287,946
-6,078
-2% -$976K
MCO icon
90
Moody's
MCO
$83.7B
$47.9M 0.28%
280,869
+143,808
+105% +$24.3M
ICE icon
91
Intercontinental Exchange
ICE
$87.2B
$46.5M 0.27%
632,657
+186,317
+42% +$13.6M
LVS icon
92
Las Vegas Sands
LVS
$31.4B
$45.5M 0.27%
595,204
+411,308
+224% +$31.4M
USB icon
93
US Bancorp
USB
$97.9B
$45M 0.27%
900,577
-124,040
-12% -$6.29M
COR
94
DELISTED
Coresite Realty Corporation
COR
$44.3M 0.26%
399,935
+182,321
+84% +$19.2M
MDLZ icon
95
Mondelez International
MDLZ
$82.9B
$43.3M 0.26%
1,056,212
-5,570
-0.5% -$224K
CVS icon
96
CVS Health
CVS
$135B
$42.2M 0.25%
655,297
-8,840
-1% -$583K
CELG
97
DELISTED
Celgene Corp
CELG
$42M 0.25%
528,640
+14,035
+3% +$1.17M
QCOM icon
98
Qualcomm
QCOM
$164B
$41.9M 0.25%
746,904
-5,474
-0.7% -$306K
LLY icon
99
Eli Lilly
LLY
$1.08T
$41.8M 0.25%
489,426
-7,797
-2% -$640K
NOC icon
100
Northrop Grumman
NOC
$76B
$41.7M 0.25%
135,380
-3,296
-2% -$1.09M

Similar funds

Aviva's Q2 2018 Portfolio in Review

As of Q2 2018, Aviva held 742 positions worth $16.9B, up 3.6% from $16.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 3.4%. Aviva opened 20 new positions and exited 5, leaving the 742-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Aviva's largest Q2 2018 buy was HDFC Bank: 300,992 shares worth $7.9M.
  • Aviva added most to UnitedHealth in Q2 2018, an estimated $52.6M increase.
  • Aviva's biggest Q2 2018 reduction was Altria Group, cutting an estimated $42.9M.
  • Aviva fully exited VanEck India Growth Leaders ETF in Q2 2018, selling an estimated $57.5M.
  • Aviva's ten largest holdings make up 19% of its $16.9B portfolio in Q2 2018.
  • Aviva opened 20 new positions and closed 5 in Q2 2018.
  • Aviva's portfolio value rose 3.6% quarter-over-quarter to $16.9B.

Based on Aviva's 13F filing for Q2 2018, filed 1 Aug 2018.